(Q63363596)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

title

Design, synthesis, and SAR studies of mefloquine-based ligands as potential antituberculosis agents (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

author name string

Sarva Jayaprakash

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Yasuyoshi Iso

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Baojie Wan

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

Alan P Kozikowski

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

publication date

1 June 2006

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

volume

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

issue

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

page(s)

593-597

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

The magic bullets and tuberculosis drug targets.

28 December 2019

cites work

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Recent advances in new structural classes of anti-tuberculosis agents

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Fighting tuberculosis: an old disease with new challenges.

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Antimicrobial activities of mefloquine and a series of related compounds

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Mefloquine is active in vitro and in vivo against Mycobacterium avium complex

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

SRI-286, a thiosemicarbazole, in combination with mefloquine and moxifloxacin for treatment of murine Mycobacterium avium complex disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Mefloquine, moxifloxacin, and ethambutol are a triple-drug alternative to macrolide-containing regimens for treatment of Mycobacterium avium disease

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Mefloquine and new related compounds target the F(0) complex of the F(0)F(1) H(+)-ATPase of Streptococcus pneumoniae

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Structure of the rotor ring of F-Type Na+-ATPase from Ilyobacter tartaricus

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Structure of the rotor of the V-Type Na+-ATPase from Enterococcus hirae

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

A diarylquinoline drug active on the ATP synthase of Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Ring closing metathesis mediated synthesis of 4a-aryloxodecahydroisoquinolines, intermediates in the preparation of novel opiates

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

A new series of highly potent non-peptide bradykinin B2 receptor antagonists incorporating the 4-heteroarylquinoline framework. Improvement of aqueous solubility and new insights into species difference

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Parallel synthesis and antimalarial screening of a 4-aminoquinoline library

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Antimalarials. 7. 2,8-Bis(trifluoromethyl)-4-quinolinemethanols

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

A novel series of selective leukotriene antagonists: exploration and optimization of the acidic region in 1,6-disubstituted indoles and indazoles

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Microplate alamar blue assay versus BACTEC 460 system for high-throughput screening of compounds against Mycobacterium tuberculosis and Mycobacterium avium

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

New perspectives on natural products in TB drug research

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

In vitro and in vivo activities of macrolide derivatives against Mycobacterium tuberculosis

1 reference

https://api.crossref.org/works/10.1002%2FCMDC.200600010

7 January 2021

Identifiers

DOI

10.1002/CMDC.200600010

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:16892398%20AND%20SRC:MED&resulttype=core&format=json

28 December 2019

1 reference